AlphaCore Capital’s Clorox CLX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$447K Sell
4,683
-63
-1% -$6.05K 0.01% 743
2026
Q1
$492K Sell
4,746
-1,748
-27% -$198K 0.01% 549
2025
Q4
$655K Buy
6,494
+2,776
+75% +$301K 0.01% 535
2025
Q3
$458K Sell
3,718
-232
-6% -$28.8K 0.02% 478
2025
Q2
$474K Sell
3,950
-3,143
-44% -$419K 0.02% 383
2025
Q1
$1.04M Buy
7,093
+2,817
+66% +$430K 0.09% 169
2024
Q4
$694K Buy
+4,276
New +$699K 0.15% 98

Other funds holding CLX

AlphaCore Capital's CLX Position: Q2 2026 in Review

AlphaCore Capital reduced its Clorox (CLX) stake by 1.3% in Q2 2026, selling an estimated $6.05K and leaving 4,683 shares worth $447K. The position accounts for 0.01% of the portfolio, ranked #743.

AlphaCore Capital first reported a position in CLX in Q4 2024 and has held it in 7 quarters since. The position peaked at $1.04M in Q1 2025. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.

  • AlphaCore Capital held 4,683 shares of Clorox worth $447K as of Q2 2026.
  • AlphaCore Capital sold 63 Clorox shares in Q2 2026, an estimated $6.05K.
  • Clorox made up 0.01% of AlphaCore Capital's portfolio in Q2 2026, its #743 holding.
  • AlphaCore Capital first reported a position in Clorox in Q4 2024 and has held it in 7 quarters since.
  • AlphaCore Capital's Clorox position peaked at $1.04M in Q1 2025.
  • 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.

Based on AlphaCore Capital's 13F filing for Q2 2026, filed 6 Aug 2026.